Such an antibody to VEGF-D has already been described (Achen et al, 2000) and was shown to block angiogenesis, lymphangiogenesis and lymph node metastasis in a VEGF-D-dependent mouse tumour model (Stacker et al, 2001). Here, VEGFD is linked to neoplasm.